PYXS
Pyxis Oncology, Inc.
Company overview
- Market capitalization
- $241.88M
- Employees
- 56
- Latest publication
- 2026-09-29
About Pyxis Oncology, Inc.
Pyxis Oncology, Inc., a clinical stage company, engages in the development of therapeutics to treat solid tumors. Its lead antibody-drug conjugates (ADC) product candidate is PYX-201, an investigational novel ADC consisting of human immunoglobulin G1 (IgG1), which is in Phase 1 clinical trial to treat patients with relapsed or refractory solid tumors; PYX-102, an investigational immunotherapeutic targeting KLRG1, an inhibitory receptor on T cells and NK cells, with potential for use as monotherapy or in combination treatments; and lead immuno-oncology (IO) product candidate is PYX-106, an investigational fully human IgG1 Siglec-15-targeting antibody that is in Phase 1 clinical trial to treat patients with advanced solid tumors. The company is also developing PYX-107, a CD40 agonist with demonstrated anti-cancer activity in patients with several cancer indications, which is in Phase 2 clinical trial for the treatment of tumors, such as soft tissue sarcomas, esophageal and gastroesophageal junction, cancers, and pancreatic ductal adenocarcinoma. It has an in-license agreement with Pfizer Inc. to develop and commercialize ADC product candidates, including micvotabart pelidotin and PYX-203, and other ADC product candidates directed to the licensed targets; and Biosion USA, Inc. for development, manufacture, and commercialization of PYX-106, an IO product candidate. Pyxis Oncology, Inc. was incorporated in 2018 and is headquartered in Boston, Massachusetts.
Financial statements
Income Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 2,820,000USD | — | 11,038,000USD | 0USD | 2,820,000USD | 0USD | 3,402,000USD | 0USD |
| Research Development | 16,057,000USD | 19,595,000USD | 21,711,000USD | 17,808,000USD | 17,133,000USD | 17,044,000USD | 14,024,000USD | 17,741,000USD |
| Total Operating Expenses | 25,990,000USD | 23,901,000USD | 29,765,000USD | 23,461,000USD | 22,570,000USD | 22,914,000USD | 40,069,000USD | 23,754,000USD |
| Income Tax Expense | 283,000USD | — | 1,103,000USD | — | 283,000USD | — | -2,164,000USD | — |
| Net Income | -25,346,000USD | -23,272,000USD | -18,106,000USD | -22,003,000USD | -18,354,000USD | -21,158,000USD | -35,571,000USD | -21,203,000USD |
| Cost Of Revenue | — | 459,000USD | -432,000USD | 0USD | 535,000USD | 552,000USD | 1,701,000USD | 731,000USD |
| Gross Profit | — | -459,000USD | 11,470,000USD | 0USD | 2,820,000USD | -552,000USD | 1,701,000USD | -731,000USD |
| Selling General Administrative | — | 4,377,000USD | 5,234,000USD | 5,653,000USD | 5,437,000USD | 5,870,000USD | 5,081,000USD | 6,013,000USD |
| Operating Income | — | -24,360,000USD | -18,295,000USD | -23,461,000USD | -19,750,000USD | -22,914,000USD | -40,069,000USD | -23,754,000USD |
| Income Before Tax | — | -23,272,000USD | -17,003,000USD | -22,003,000USD | -18,071,000USD | -21,158,000USD | -37,735,000USD | -21,203,000USD |
| Ebit | — | -24,360,000USD | -18,287,000USD | -22,003,000USD | -19,750,000USD | -22,914,000USD | -19,105,000USD | -23,754,000USD |
| Ebitda | — | -23,901,000USD | -15,398,000USD | -21,468,000USD | -19,215,000USD | -22,362,000USD | -18,555,000USD | -23,023,000USD |
| Depreciation And Amortization | — | 459,000USD | 2,889,000USD | 535,000USD | 535,000USD | 552,000USD | 550,000USD | 731,000USD |
| Total Other Income Expense Net | — | 1,088,000USD | 1,292,000USD | 1,458,000USD | 1,679,000USD | 1,756,000USD | 2,334,000USD | 2,551,000USD |
| Unclassified Operating Expenses | — | — | 2,820,000USD | — | — | — | 20,964,000USD | — |
| Interest Income | — | — | 600,000USD | 774,000USD | 995,000USD | 1,241,000USD | 1,620,000USD | 1,846,000USD |
| Net Interest Income | — | — | 600,000USD | 774,000USD | 995,000USD | 1,241,000USD | 1,620,000USD | 1,846,000USD |
| Tax Provision | — | — | 1,103,000USD | 0USD | 283,000USD | — | — | 0USD |
| Net Income From Continuing Ops | — | — | -18,106,000USD | -22,003,000USD | -18,354,000USD | -21,158,000USD | -35,571,000USD | -21,203,000USD |
| Reconciled Depreciation | — | — | 2,897,000USD | 527,000USD | 535,000USD | 552,000USD | 550,000USD | 731,000USD |
| Selling And Marketing Expenses | — | — | — | 684,000USD | — | — | — | — |
| Source | DisclosurePreliminary | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Income Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD |
|---|---|---|---|---|---|---|---|
| Total Revenue | 13,858,000USD | 16,146,000USD | 0USD | 0USD | 0USD | 0USD | 0USD |
| Cost Of Revenue | 2,388,000USD | 475,000USD | 2,000,000USD | 1,836,000USD | 1,251,000USD | 444,000USD | — |
| Gross Profit | 11,470,000USD | 15,671,000USD | -2,000,000USD | -1,836,000USD | -1,251,000USD | -444,000USD | — |
| Research Development | 73,696,000USD | 58,747,000USD | 49,586,000USD | 86,129,000USD | 51,054,000USD | 8,604,000USD | 1,224,000USD |
| Selling General Administrative | 22,194,000USD | 25,420,000USD | 32,610,000USD | 37,352,000USD | 18,663,000USD | 3,846,000USD | 1,655,000USD |
| Total Operating Expenses | 95,890,000USD | 105,131,000USD | 82,196,000USD | 123,481,000USD | 69,717,000USD | 12,450,000USD | 2,879,000USD |
| Operating Income | -84,420,000USD | -89,460,000USD | -82,196,000USD | -123,481,000USD | -69,717,000USD | -12,894,000USD | -2,879,000USD |
| Interest Income | 3,610,000USD | 7,039,000USD | 6,908,000USD | 2,764,000USD | 23,000USD | 66,000USD | 107,000USD |
| Net Interest Income | 3,610,000USD | 7,039,000USD | 6,908,000USD | 2,764,000USD | 23,000USD | 66,000USD | 107,000USD |
| Income Before Tax | -78,235,000USD | -79,495,000USD | -73,790,000USD | -120,717,000USD | -75,975,000USD | -12,828,000USD | -2,772,000USD |
| Income Tax Expense | 1,386,000USD | -2,164,000USD | 1,776,000USD | -2,764,000USD | 5,561,000USD | -66,000USD | -107,000USD |
| Tax Provision | 1,386,000USD | -2,164,000USD | 0USD | — | — | — | — |
| Net Income | -79,621,000USD | -77,331,000USD | -73,790,000USD | -117,953,000USD | -75,975,000USD | -12,828,000USD | -2,665,000USD |
| Net Income From Continuing Ops | -79,621,000USD | -77,331,000USD | -94,294,000USD | -120,717,000USD | -75,975,000USD | -12,828,000USD | -2,772,000USD |
| Ebit | -84,420,000USD | -68,496,000USD | -82,196,000USD | -123,481,000USD | -69,717,000USD | -12,828,000USD | -2,879,000USD |
| Ebitda | -79,909,000USD | -65,514,000USD | -80,269,000USD | -122,772,000USD | -69,070,000USD | -12,384,000USD | -2,772,000USD |
| Depreciation And Amortization | 4,511,000USD | 2,982,000USD | 1,927,000USD | 709,000USD | 647,000USD | 444,000USD | 107,000USD |
| Reconciled Depreciation | 4,511,000USD | 2,982,000USD | 1,429,000USD | 709,000USD | 647,000USD | 469,000USD | 0USD |
| Total Other Income Expense Net | 6,185,000USD | 9,965,000USD | 8,406,000USD | 2,764,000USD | -6,258,000USD | 66,000USD | 107,000USD |
| Unclassified Operating Expenses | — | 20,964,000USD | — | — | — | — | — |
| Interest Expense | — | — | — | 2,764,000USD | 6,258,000USD | 0USD | 0USD |
| Non Operating Income Net Other | — | — | — | 2,764,000USD | -6,258,000USD | — | — |
| Net Income Applicable To Common Shares | — | — | — | -120,717,000USD | -75,975,000USD | -12,828,000USD | -2,772,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 54,922,000USD | 64,300,000USD | 91,520,000USD | 105,604,000USD | 123,215,000USD | 135,867,000USD | 157,181,000USD | 195,311,000USD |
| Cash And Equivalents | 18,855,000USD | — | — | — | — | — | — | — |
| Cash And Short Term Investments | 32,996,000USD | 42,490,000USD | 66,857,000USD | 77,728,000USD | 88,944,000USD | 105,432,000USD | 126,931,000USD | 144,818,000USD |
| Short Term Investments | 14,141,000USD | 35,252,000USD | 51,435,000USD | 67,337,000USD | 78,211,000USD | 92,673,000USD | 107,458,000USD | 132,762,000USD |
| Total Current Assets | 36,734,000USD | 45,572,000USD | 72,105,000USD | 83,073,000USD | 99,956,000USD | 111,871,000USD | 132,440,000USD | 148,868,000USD |
| Total Liabilities | 43,482,000USD | — | — | — | — | — | — | — |
| Total Current Liabilities | 27,474,000USD | 16,532,000USD | 21,131,000USD | 19,382,000USD | 17,678,000USD | 14,430,000USD | 17,680,000USD | 20,320,000USD |
| Other Current Liabilities | 12,381,000USD | — | — | — | — | — | — | — |
| Total Stockholder Equity | 11,440,000USD | 31,268,000USD | 53,408,000USD | 68,779,000USD | 87,643,000USD | 103,103,000USD | 120,751,000USD | 153,680,000USD |
| Total Equity Including Noncontrolling Interest | 11,440,000USD | — | — | — | — | — | — | — |
| Property Plant Equipment Net | 18,188,000USD | 18,728,000USD | 19,415,000USD | 20,097,000USD | 20,771,000USD | 21,452,000USD | 22,141,000USD | 22,824,000USD |
| Accounts Payable | 3,269,000USD | 4,989,000USD | 10,885,000USD | 9,756,000USD | 9,412,000USD | 2,846,000USD | 4,859,000USD | 4,870,000USD |
| Short Term Debt | 1,824,000USD | 1,757,000USD | 1,692,000USD | 1,630,000USD | 1,568,000USD | 1,508,000USD | 1,450,000USD | 1,393,000USD |
| Common Stock | 63,000USD | 63,000USD | 63,000USD | 62,000USD | 62,000USD | 62,000USD | 60,000USD | 59,000USD |
| Retained Earnings | -491,795,000USD | -466,449,000USD | -443,177,000USD | -425,071,000USD | -403,068,000USD | -384,714,000USD | -363,556,000USD | -327,985,000USD |
| Accumulated Other Comprehensive Income | -4,000USD | — | 53,000USD | 69,000USD | -5,000USD | 49,000USD | 170,000USD | 351,000USD |
| Other Current Assets | — | 3,082,000USD | 4,548,000USD | 5,345,000USD | 8,012,000USD | 6,439,000USD | 5,509,000USD | 4,050,000USD |
| Total Liab | — | 33,031,999USD | 38,112,000USD | 36,825,000USD | 35,572,000USD | 32,764,000USD | 36,430,000USD | 41,631,000USD |
| Other Current Liab | — | 9,786,000USD | 8,554,000USD | 7,996,000USD | 6,698,000USD | 10,076,000USD | 11,371,000USD | 14,057,000USD |
| Cash | — | 7,238,000USD | 15,422,000USD | 10,391,000USD | 10,733,000USD | 12,759,000USD | 19,473,000USD | 12,056,000USD |
| Net Debt | — | 11,019,000USD | 3,251,000USD | 8,682,000USD | 8,729,000USD | 7,083,000USD | 727,000USD | 8,484,000USD |
| Short Long Term Debt Total | — | 18,257,000USD | 18,673,000USD | 19,073,000USD | 19,462,000USD | 19,842,000USD | 20,200,000USD | 20,540,000USD |
| Common Stock Shares Outstanding | — | 63,469,850shares | 62,143,166shares | 62,557,386shares | 61,918,826shares | 61,048,948shares | 60,715,041shares | 60,715,041shares |
| Non Current Assets Total | — | 18,727,999USD | 19,415,000USD | 22,531,000USD | 23,259,000USD | 23,996,000USD | 24,741,000USD | 46,443,000USD |
| Non Current Liabilities Total | — | 16,499,999USD | 16,981,000USD | 17,443,000USD | 17,894,000USD | 18,334,000USD | 18,750,000USD | 21,311,000USD |
| Unclassified Non Current Liabilities | — | 16,499,999USD | 16,981,000USD | 17,443,000USD | 17,894,000USD | 18,334,000USD | 18,750,000USD | 21,311,000USD |
| Unclassified Equity | — | 497,654,000USD | 496,406,000USD | 493,657,000USD | 490,592,000USD | 487,644,000USD | 484,017,000USD | 481,196,000USD |
| Capital Stock | — | — | 63,000USD | 62,000USD | 62,000USD | 62,000USD | 60,000USD | 59,000USD |
| Net Receivables | — | — | 700,000USD | — | 3,000,000USD | — | — | — |
| Property Plant Equipment Gross | — | — | 26,422,000USD | 20,097,000USD | 20,771,000USD | 21,452,000USD | 27,374,000USD | 22,824,000USD |
| Net Working Capital | — | — | 50,974,000USD | 63,691,000USD | 82,278,000USD | 97,441,000USD | 114,760,000USD | 128,548,000USD |
| Intangible Assets | — | — | — | 2,434,000USD | 2,488,000USD | 2,544,000USD | 2,600,000USD | 23,619,000USD |
| Good Will | — | — | — | — | — | 2,544,000USD | — | — |
| Unclassified Non Current Assets | — | — | — | — | — | -2,544,000USD | — | — |
| Current Deferred Revenue | — | — | — | — | — | — | — | -15,450,000USD |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD |
|---|---|---|---|---|---|---|---|
| Total Assets | 91,520,000USD | 157,181,000USD | 173,726,000USD | 211,379,000USD | 280,021,000USD | 10,151,000USD | 19,807,000USD |
| Other Current Assets | 4,548,000USD | 5,509,000USD | 5,285,000USD | 6,721,000USD | 3,938,000USD | 23,000USD | 11,000USD |
| Total Liab | 38,112,000USD | 36,430,000USD | 48,022,000USD | 50,555,000USD | 18,708,000USD | 25,796,000USD | 22,681,000USD |
| Total Stockholder Equity | 53,408,000USD | 120,751,000USD | 125,704,000USD | 160,824,000USD | 261,313,000USD | -15,645,000USD | -2,874,000USD |
| Other Current Liab | 8,554,000USD | 11,371,000USD | 12,971,000USD | 24,537,000USD | 6,592,000USD | 1,933,000USD | 124,000USD |
| Common Stock | 63,000USD | 60,000USD | 45,000USD | 34,000USD | 32,000USD | 1,000USD | 1,000USD |
| Capital Stock | 63,000USD | 60,000USD | 45,000USD | 34,000USD | 32,000USD | 1,000USD | 1,000USD |
| Retained Earnings | -443,177,000USD | -363,556,000USD | -286,225,000USD | -212,435,000USD | -91,718,000USD | -15,743,000USD | -2,915,000USD |
| Cash | 15,422,000USD | 19,473,000USD | 9,664,000USD | 179,293,000USD | 274,735,000USD | 8,080,000USD | 19,690,000USD |
| Cash And Short Term Investments | 66,857,000USD | 126,931,000USD | 119,298,000USD | 179,293,000USD | 274,735,000USD | 8,080,000USD | 19,690,000USD |
| Total Current Assets | 72,105,000USD | 132,440,000USD | 124,604,000USD | 186,612,000USD | 278,673,000USD | 8,103,000USD | 19,701,000USD |
| Total Current Liabilities | 21,131,000USD | 17,680,000USD | 25,759,000USD | 31,634,000USD | 18,708,000USD | 3,689,000USD | 733,000USD |
| Net Debt | 3,251,000USD | 727,000USD | 11,667,000USD | -160,372,000USD | -274,570,000USD | -7,300,000USD | -19,675,000USD |
| Short Term Debt | 1,692,000USD | 1,450,000USD | 1,232,000USD | — | 165,000USD | 615,000USD | 9,000USD |
| Short Long Term Debt Total | 18,673,000USD | 20,200,000USD | 21,331,000USD | 18,921,000USD | 165,000USD | 780,000USD | 15,000USD |
| Short Term Investments | 51,435,000USD | 107,458,000USD | 109,634,000USD | 0USD | — | — | — |
| Net Receivables | 700,000USD | — | 21,000USD | 598,000USD | — | — | — |
| Accounts Payable | 10,885,000USD | 4,859,000USD | 3,896,000USD | 7,097,000USD | 11,951,000USD | 1,077,000USD | 491,000USD |
| Property Plant Equipment Net | 19,415,000USD | 22,141,000USD | 24,814,000USD | 24,767,000USD | 1,239,000USD | 1,939,000USD | 76,000USD |
| Property Plant Equipment Gross | 26,422,000USD | 27,374,000USD | 28,416,000USD | 24,767,000USD | 1,239,000USD | 2,408,000USD | 76,000USD |
| Accumulated Other Comprehensive Income | 53,000USD | 170,000USD | 63,000USD | — | -280,021,000USD | -21,942,000USD | -21,942,000USD |
| Common Stock Shares Outstanding | 62,143,166shares | 58,445,765shares | 39,904,603shares | 33,033,081shares | 32,222,881shares | 34,309,101shares | 34,309,101shares |
| Non Current Assets Total | 19,415,000USD | 24,741,000USD | 49,122,000USD | 24,767,000USD | 1,348,000USD | 2,048,000USD | 106,000USD |
| Non Current Liabilities Total | 16,981,000USD | 18,750,000USD | 22,263,000USD | 18,921,000USD | 12,116,000USD | 22,107,000USD | 21,948,000USD |
| Net Working Capital | 50,974,000USD | 114,760,000USD | 98,845,000USD | 154,978,000USD | 259,965,000USD | 4,414,000USD | 18,968,000USD |
| Unclassified Non Current Liabilities | 16,981,000USD | 18,750,000USD | 22,263,000USD | — | 12,116,000USD | 22,107,000USD | 21,948,000USD |
| Unclassified Equity | 496,406,000USD | 484,017,000USD | 411,776,000USD | 373,191,000USD | 632,988,000USD | 22,038,000USD | 21,981,000USD |
| Intangible Assets | — | 2,600,000USD | 24,308,000USD | — | — | — | — |
| Current Deferred Revenue | — | — | 7,660,000USD | — | 6,326,000USD | 1,945,000USD | 224,000USD |
| Inventory | — | — | — | 874,000USD | — | — | — |
| Non Current Liabilities Other | — | — | — | 18,921,000USD | — | — | — |
| Non Currrent Assets Other | — | — | — | 13,602,000USD | 109,000USD | 109,000USD | 30,000USD |
| Net Tangible Assets | — | — | — | 160,824,000USD | 261,313,000USD | -15,645,000USD | -2,874,000USD |
| Unclassified Non Current Assets | — | — | — | -13,602,000USD | — | — | — |
| Other Assets | — | — | — | — | 109,000USD | 109,000USD | 0USD |
| Unclassified Current Liabilities | — | — | — | — | -6,326,000USD | -1,881,000USD | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow YTD
| Metric | Q2 20262026-06-30 · USD |
|---|---|
| Depreciation | 760,000USD |
| Stock Based Compensation | 6,738,000USD |
| Change To Account Receivables | 0USD |
| Change To Liabilities | -3,789,000USD |
| Change In Working Capital | -6,106,000USD |
| Operating Cash Flow | -44,206,000USD |
| Net Investments | -13,993,000USD |
| Unclassified Investing Cash Flow | 51,663,000USD |
| Investing Cash Flow | 37,670,000USD |
| Net Common Stock Issuance | -78,000USD |
| Unclassified Financing Cash Flow | 10,047,000USD |
| Financing Cash Flow | 9,969,000USD |
| Change In Cash | 3,433,000USD |
| End Cash Flow | 20,327,000USD |
| Source | DisclosureDeterministicFinal |
Cash flow Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -23,272,000USD | -18,106,000USD | -22,003,000USD | -18,354,000USD | -21,158,000USD | -35,571,000USD | -21,203,000USD | -17,301,000USD |
| Depreciation | 459,000USD | 2,897,000USD | 527,000USD | 535,000USD | 552,000USD | 550,000USD | 731,000USD | 585,000USD |
| Other Non Cash Items | 1,199,000USD | -156,000USD | -322,000USD | -694,000USD | -964,000USD | 19,617,000USD | -1,473,000USD | -1,465,000USD |
| Change In Working Capital | -4,386,000USD | 2,856,000USD | 5,448,000USD | -1,765,000USD | -4,596,000USD | -6,659,000USD | 4,299,000USD | 12,303,000USD |
| Total Cash From Operating Activities | -26,000,000USD | -10,427,000USD | -13,277,000USD | -17,263,000USD | -22,535,000USD | -19,290,000USD | -14,665,000USD | -3,007,000USD |
| Capital Expenditures | 0USD | 0USD | -9,000USD | 0USD | 0USD | 0USD | 0USD | 0USD |
| Free Cash Flow | -26,000,000USD | -10,427,000USD | -13,286,000USD | -17,263,000USD | -22,535,000USD | -19,290,000USD | -14,665,000USD | -3,007,000USD |
| Total Cashflows From Investing Activities | 16,369,000USD | 16,261,000USD | 11,471,000USD | 15,304,000USD | 15,821,000USD | 26,657,000USD | -8,000USD | 4,000USD |
| Total Cash From Financing Activities | -25,000USD | 669,000USD | -8,000USD | -67,000USD | 0USD | 50,000USD | 1,655,000USD | 110,000USD |
| Change In Cash | -9,656,000USD | 6,503,000USD | -1,814,000USD | -2,026,000USD | -6,714,000USD | 7,417,000USD | -13,018,000USD | -2,893,000USD |
| Begin Period Cash Flow | 16,894,000USD | 10,391,000USD | 12,205,000USD | 14,231,000USD | 20,945,000USD | 13,528,000USD | 26,546,000USD | 29,439,000USD |
| End Period Cash Flow | 7,238,000USD | 16,894,000USD | 10,391,000USD | 12,205,000USD | 14,231,000USD | 20,945,000USD | 13,528,000USD | 26,546,000USD |
| Other Cashflows From Financing Activities | -25,000USD | -71,000USD | -8,000USD | -67,000USD | -2,000USD | 50,000USD | 176,000USD | 5,000USD |
| Unclassified Investing Cash Flow | 16,369,000USD | 107,312,000USD | -149,601,000USD | — | -67,173,000USD | — | -137,483,000USD | — |
| Stock Based Compensation | — | 2,082,000USD | 3,073,000USD | 3,015,000USD | 3,631,000USD | 2,773,000USD | 2,981,000USD | 2,871,000USD |
| Investments | — | 16,261,000USD | 11,471,000USD | 15,304,000USD | 15,821,000USD | 26,657,000USD | -8,000USD | 4,000USD |
| Issuance Of Capital Stock | — | 2,000USD | -2,000USD | 0USD | 2,000USD | 0USD | 1,584,000USD | 105,000USD |
| Other Cashflows From Investing Activities | — | -107,312,000USD | 149,610,000USD | — | 67,173,000USD | — | 137,483,000USD | — |
| Change To Account Receivables | — | — | 3,000,000USD | -3,000,000USD | 0USD | — | — | 8,000,000USD |
| Sale Purchase Of Stock | — | — | — | -67,000USD | — | -7,650,000USD | -1,000USD | -43,000USD |
| Unclassified Financing Cash Flow | — | — | — | — | — | 7,650,000USD | 1,480,000USD | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD |
|---|---|---|---|---|---|---|---|
| Net Income | -79,621,000USD | -77,331,000USD | -73,790,000USD | -120,717,000USD | -75,975,000USD | -12,828,000USD | -2,772,000USD |
| Depreciation | 4,511,000USD | 2,982,000USD | 1,927,000USD | 709,000USD | 647,000USD | 469,000USD | 469,000USD |
| Stock Based Compensation | 11,801,000USD | 12,945,000USD | 16,946,000USD | 15,764,000USD | 6,441,000USD | 44,000USD | 28,000USD |
| Other Non Cash Items | -2,136,000USD | 15,555,000USD | -4,128,000USD | 10,408,000USD | 20,604,000USD | -56,000USD | -264,000USD |
| Change In Working Capital | 1,943,000USD | -11,823,000USD | -11,664,000USD | 4,501,000USD | 6,676,000USD | 2,287,000USD | 505,000USD |
| Total Cash From Operating Activities | -63,502,000USD | -57,672,000USD | -70,709,000USD | -89,335,000USD | -35,326,000USD | -10,084,000USD | -2,239,000USD |
| Capital Expenditures | -9,000USD | -237,000USD | -6,726,000USD | -6,399,000USD | -540,000USD | -1,483,000USD | -1,483,000USD |
| Free Cash Flow | -63,511,000USD | -57,909,000USD | -77,435,000USD | -95,734,000USD | -35,866,000USD | -11,567,000USD | -2,239,000USD |
| Investments | 58,866,000USD | 8,155,000USD | -116,935,000USD | -6,399,000USD | -50,000USD | -1,483,000USD | -50,000USD |
| Total Cashflows From Investing Activities | 58,857,000USD | 8,155,000USD | -104,849,000USD | -6,399,000USD | -590,000USD | -1,483,000USD | -1,483,000USD |
| Total Cash From Financing Activities | 594,000USD | 59,326,000USD | 5,929,000USD | 183,000USD | 304,044,000USD | 35,000USD | 21,955,000USD |
| Issuance Of Capital Stock | 2,000USD | 59,046,000USD | 6,122,000USD | 152,296,000USD | 303,877,000USD | 35,000USD | 21,955,000USD |
| Change In Cash | -4,051,000USD | 9,809,000USD | -169,629,000USD | -95,551,000USD | 268,128,000USD | -11,532,000USD | 19,716,000USD |
| Begin Period Cash Flow | 20,945,000USD | 11,136,000USD | 180,765,000USD | 276,316,000USD | 8,188,000USD | 19,720,000USD | 4,000USD |
| End Period Cash Flow | 16,894,000USD | 20,945,000USD | 11,136,000USD | 180,765,000USD | 276,316,000USD | 8,188,000USD | 19,720,000USD |
| Other Cashflows From Investing Activities | 165,871,000USD | 168,510,000USD | — | — | -50USD | — | — |
| Other Cashflows From Financing Activities | -148,000USD | 280,000USD | -193,000USD | 183,000USD | 151,748,000USD | 32,000USD | 43,897,000USD |
| Unclassified Investing Cash Flow | -165,871,000USD | -168,273,000USD | 18,812,000USD | 6,399,000USD | — | 1,483,000USD | — |
| Sale Purchase Of Stock | — | — | -445USD | 183,000USD | 304,044,000USD | — | — |
| Unclassified Financing Cash Flow | — | — | 6,122,445USD | — | -151,748,000USD | — | -43,897,000USD |
| Change To Liabilities | — | — | — | 3,623,000USD | 9,735,000USD | 558,000USD | 292,000USD |
| Cash And Cash Equivalents Changes | — | — | — | -95,551,000USD | 268,128,000USD | — | — |
| Unclassified Operating Cash Flow | — | — | — | — | 6,281,000USD | — | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Operating metrics
No operating metrics are currently published for this company.
Revenue breakdown
| Period | Dimension | Business / region | Revenue | Currency | Source |
|---|---|---|---|---|---|
| FY 2025Yearly · 2025-12-31 | Product | Milestone Revenue | 2,820,000 | USD | 0001193125-26-118532 |
| FY 2025Yearly · 2025-12-31 | Product | Other | 38,000 | USD | 0001193125-26-118532 |
| FY 2025Yearly · 2025-12-31 | Product | Royalty | 0 | USD | 0001193125-26-118532 |
| FY 2025Yearly · 2025-12-31 | Product | Sale Of Royalty Rights | 11,000,000 | USD | 0001193125-26-118532 |
| FY 2024Yearly · 2024-12-31 | Product | Milestone Revenue | 0 | USD | 0001193125-26-118532 |
| FY 2024Yearly · 2024-12-31 | Product | Royalty | 8,146,000 | USD | 0001193125-26-118532 |
| FY 2024Yearly · 2024-12-31 | Product | Sale Of Royalty Rights | 8,000,000 | USD | 0001193125-26-118532 |
| Q1 2024Quarterly · 2024-03-31 | Product | Royalty | 8,146,000 | USD | 0000950170-25-071996 |
| Q1 2024Quarterly · 2024-03-31 | Product | Sale Of Royalty Rights | 8,000,000 | USD | 0000950170-25-071996 |
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.